MedTrace Logo

JUPITER Study: Transapical Aortic Valve Implantation for Aortic Regurgitation

NCT01598844 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2020-11-24

No results posted yet for this study

Summary

The purpose of this registry is to observe longterm performance and safety of the JenaValve TAVI system, in routine medical and everyday conditions.

Conditions

  • Aortic Stenosis
  • Aortic Insufficiency
  • Aortic Regurgitation

Interventions

DEVICE

Transcatheter aortic valve replacement

Transcatheter aortic valve replacement via a transapical access

Sponsors & Collaborators

  • King's College London

    collaborator OTHER

  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER

  • JenaValve Technology, Inc.

    lead INDUSTRY

Principal Investigators

  • Olaf Wendler, Prof · King's College Hospital NHS Trust

  • Hendrik Treede, Prof · University Heart Center Hamburg

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-30
Primary Completion
2015-08-27
Completion
2018-07-31

Countries

  • Germany
  • Netherlands
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01598844 on ClinicalTrials.gov